Cytokine and hormonal profile in blood serum and follicular fluids during ovarian stimulation with the multidose antagonist or the long agonist protocol
Open Access
- 27 September 2006
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 21 (12), 3091-3095
- https://doi.org/10.1093/humrep/del207
Abstract
BACKGROUND: The aim of our study was to explore cytokine and hormonal profiles in blood and follicular fluids from normal women stimulated with either the multidose antagonist or the long agonist protocol. METHODS: Fifty-six patients were stimulated with the multidose antagonist protocol and 12 with the long agonist protocol. Interleukin (IL)-1β, IL-6, tumour necrosis factor-α (TNFα), leptin, vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), estradiol (E2), progesterone and testosterone levels were measured in serum and follicular fluids by immunoassays. RESULTS: The two treatment groups had similar cytokine concentrations in serum. The intrafollicular concentrations of IL-1β, IL-6, VEGF and leptin were also similar in the two groups. The concentrations of bFGF in follicular fluids from the antagonist group (169.5 ± 113.2 ng/ml) were lower than those from the agonist group (249.7 ± 119.8 ng/ml). bFGF concentrations were correlated with the amount of administered gonadotrophins (R = 0.364, P < 0.01) which was significantly lower in the antagonist group (antagonist group: 2037.7 ± 725.8 IU; agonist group: 2836.4 ± 1163.5 IU). CONCLUSIONS: Normal women stimulated with either the multidose antagonist or the long agonist protocol generally have similar cytokine profiles in serum and follicular fluids. The intrafollicular levels of bFGF tend to be lower in antagonist cycles because of the lower amount of administered gonadotrophins.Keywords
This publication has 21 references indexed in Scilit:
- Basic fibroblast growth factor induces primordial follicle development and initiates folliculogenesisMolecular and Cellular Endocrinology, 2001
- Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulationHuman Reproduction, 2001
- Efficacy and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyperstimulationFertility and Sterility, 2001
- Basic Fibroblast Growth Factor Inhibits Apoptosis of Spontaneously Immortalized Granulosa Cells by Regulating Intracellular Free Calcium Levels through a Protein Kinase Cδ-Dependent Pathway**This work was supported by NIH Grant HD-33467.Endocrinology, 2000
- Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trialHuman Reproduction, 2000
- Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelinHuman Reproduction, 2000
- Cytokines in the follicular fluid of stimulated and non-stimulated human ovaries; is ovulation a suppressed inflammatory reaction?Human Reproduction, 1999
- MACROPHAGE-DERIVED CYTOKINES IN THE FOLLICULAR FLUIDS OF WOMEN WITH INFERTILITY DUE TO IMMUNOLOGICAL CAUSES. ELEVATED LEVELS OF INTERLEUKIN 6 AND LOW LEVELS OF GRANULOCYTE–MACROPHAGE COLONY-STIMULATING FACTORCytokine, 1998
- The follicular and endocrine environment in women with endometriosis: local and systemic cytokine productionFertility and Sterility, 1998
- Relationship between tumour necrosis factor and sex steroid concentrations in the follicular fluid of women with immunological infertilityHuman Reproduction, 1996